ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Drug therapy for neonatal abstinence syndrome (NAS) based on patient body weight

Drug therapy for neonatal abstinence syndrome (NAS) based on patient body weight
Initial opioid therapy
Drug Initial dose Incremental increase based on symptoms Maximum dose Weaning based on abstinence scoring
Morphine

0.04 mg/kg every three to four hours given orally

Oral dose should be given with feeds
0.04 mg/kg per dose 0.2 mg/kg per dose

Taper dose by 10 to 20 percent every two to three days

Discontinue morphine when the dose is weaned to 0.04 mg/kg per day without any increase in abstinence scores
Methadone 0.05 to 0.1 mg/kg every six hours given orally 0.05 mg/kg per dose To effect

Taper dose by 10 to 20 percent per week

Discontinue when a dose of 0.05 mg/kg per day is reached
Phenobarbital used in combination with opioid therapy for infants with severe NAS or with multidrug exposure
  Loading dose Maintenance dose Therapeutic plasma goal Weaning
Phenobarbital Single loading dose of 15 to 20 mg/kg given orally, intravenously, or intramuscularly. If symptoms are still severe 8 to 12 hours after initial dose, the dose can be repeated once (total cumulative maximum loading of 40 mg/kg).

3 to 4 mg/kg per day started 12 to 24 hours after initial dose

Administered as a single dose in the evening OR two divided doses given every 12 hours

Increase dose by 1 to 5 mg/kg per day until therapeutic plasma levels are achieved
Therapeutic goal of trough plasma concentration level between 20 and 30 mg/dL (86 and 129 micromoles/L), obtained 24 to 48 hours after initiation or change in dosing

Phenobarbital should be weaned after morphine is fully tapered off

Taper phenobarbital dose to decrease drug concentration by 10 to 20 percent per day
Data from:
  1. Hudak ML, Tan RC, Committee on Drugs, et al. Neonatal drug withdrawal. Pediatrics 2012; 129:e540.
  2. Bio LL, Siu A, Poon CY. Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol 2011; 31:692.
  3. Tran JH. Treatment of neonatal abstinence syndrome. J Pediatr Health Care 1999; 13:295.
Graphic 85854 Version 8.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟